Mark Bodmer serves as Executive at Evelo Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Mark Bodmer has executed 9 insider transactions totaling $45.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 8, 2023 involved selling 3,163 shares valued at $1.0K.
Mark Bodmer currently holds 25,732 shares of Evelo Biosciences, Inc. (EVLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Bodmer has been a net seller of EVLO stock. They have purchased $0 and sold $45.1K worth of shares.
Mark Bodmer's most recent insider trade was on Nov 8, 2023, when they sold 3,163 shares at $0.33 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| Nov 2, 2023 | EVLO | $2.3K | Sale | 6,854 | $0.33 | Planned |
| Nov 1, 2023 | EVLO | $0 | Option Exercise | 12,500 | $N/A | Planned |
| Aug 8, 2023 | EVLO | $29.7K | Sale | 3,128 | $9.51 | Planned |
| Aug 7, 2023 | EVLO | $0 | Option Exercise | 6,625 | $N/A | Planned |
| May 23, 2023 | EVLO | $3.2K | Sale | 22,571 | $0.14 | Planned |
| May 8, 2023 | EVLO | $8.8K | Sale | 68,014 | $0.13 | Planned |
| May 7, 2023 | EVLO | $0 | Option Exercise | 132,500 | $N/A | Discretionary |